Acute pulmonary embolism in COVID-19 related hypercoagulability

26Citations
Citations of this article
149Readers
Mendeley users who have this article in their library.

Abstract

Since December 2019, a novel Coronavirus (SARS-CoV-2) was confirmed as the etiologic agent of a worldwide outbreak of a pneumonia that can result in severe respiratory failure. This clinical entity seems to be associated with a marked hypercoagulable state that causes both arterial and venous thromboembolic complications. Therefore, an adequate anti-thrombotic prophylaxis is recommended in hospitalized COVID-19 patients. Although rapidly worsening respiratory symptoms in a patient with SARS-CoV-2 respiratory infection may correlate with worsening pneumonia itself, it may also mask a pulmonary embolism. We report the case of a 50-year-old man affected by SARS-CoV-2 pneumonia, who developed acute pulmonary embolism.

Cite

CITATION STYLE

APA

Lorenzo, C., Francesca, B., Francesco, P., Elena, C., Luca, S., & Paolo, S. (2020). Acute pulmonary embolism in COVID-19 related hypercoagulability. Journal of Thrombosis and Thrombolysis, 50(1), 223–226. https://doi.org/10.1007/s11239-020-02160-1

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free